FIELD: biochemistry.
SUBSTANCE: invention relates to pharmaceutical agents contain factor VII polypeptides and factor IX polypeptides or related polypeptides. Moreover polypeptides for drug production are characterized and methods for prophylaxis and treatment of episodic hemorrhage in subject.
EFFECT: more effective method for treatment of episodic hemorrhage in subject.
43 cl, 1 tbl, 5 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED APPLICATION OF FACTOR VII POLYPEPTIDES AND FACTOR VIII POLYPEPTIDES | 2002 |
|
RU2311923C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING FACTOR VII POLYPEPTIDES AND FACTOR XI POLYPEPTIDES | 2002 |
|
RU2298416C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VII POLYPEPTIDES AND PAI-1 POLYPEPTIDES | 2002 |
|
RU2304980C2 |
| LIQUID COMPOSITION OF FACTOR VII POLYPEPTIDES | 2002 |
|
RU2357751C2 |
| FACTOR VII CHIMERIC MOLECULES | 2010 |
|
RU2563231C2 |
| DERIVATIVES OF FACTOR OF VII BLOOD COAGULATION | 2002 |
|
RU2338752C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VIIA AND FACTOR XIII | 2001 |
|
RU2272648C2 |
| MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE | 2007 |
|
RU2466141C2 |
| STABILISATION OF PROTEIN IN SOLUTION | 2004 |
|
RU2364609C2 |
| MODIFIED VITAMIN K DEPENDENT POLYPEPTIDES | 2005 |
|
RU2396347C2 |
